ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

CYT Cyteir Therapeutics Inc

3,02
0,00 (0,00%)
Après les heures de négociation
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Cyteir Therapeutics Inc CYT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 3,02 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,02 3,02
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
07/3/202422:31EDGAR2Form 8-K - Current report
07/3/202422:30BWCyteir Announces Timeline for Voluntarily Delisting from..
06/3/202400:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202401:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202401:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/12/202322:00EDGAR2Form 8-K - Current report
14/12/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202322:05EDGAR2Form 8-K - Current report
05/12/202322:05EDGAR2Form 8-K - Current report
22/11/202319:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202322:01EDGAR2Form 8-K - Current report
06/11/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/10/202322:14EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
12/10/202313:52EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/10/202313:51EDGAR2Form 8-K - Current report
12/10/202313:30BWOngoing Results From a Dose Expansion Cohort of CYT-0851 in..
05/10/202322:00EDGAR2Form 8-K - Current report
02/10/202322:44EDGAR2Form PREM14A - Preliminary proxy statements relating to..
07/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/6/202323:29EDGAR2Form 144 - Report of proposed sale of securities
30/6/202316:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/6/202316:22EDGAR2Form 8-K - Current report
30/6/202314:00BWCyteir Therapeutics Announces Discontinuation of CYT-0851..
03/6/202315:00BWPreliminary Ongoing Results with CYT-0851 in Combination..
10/5/202322:01BWCyteir Therapeutics Reports First Quarter 2023 Financial..

Dernières Valeurs Consultées

Delayed Upgrade Clock